Frank Pk Hsu Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2018

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Pk Hsu Research Topics

Disease

1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 01/2015
1	Pain (Aches) 01/2015
1	Brain Edema (Cerebral Edema) 05/2011
1	Brain Injuries (Brain Injury) 05/2011
1	Inflammation (Inflammations) 05/2011

Drug/Important Bio-Agent (IBA)

1	Bevacizumab (Avastin)FDA Link 01/2018
1	VaccinesIBA 01/2018
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2015
1	HydrogenIBA 05/2011
1	Neuroprotective AgentsIBA 05/2011

Therapy/Procedure

1	Spinal Cord Stimulation 01/2015
1	Operative Surgical Procedures 05/2011